Top of page

Friday 17 April marks Waldenström’s macroglobulinaemia World Awareness Day – a day to raise awareness of this rare type of lymphoma and connect the community.

Waldenström’s macroglobulinaemia (WM) was first described in 1944 and is named after Jan G. Waldenström, a Swedish oncologist and scientist.

WM is a type of low-grade (slow-growing) non-Hodgkin lymphoma. It develops from B lymphocytes (a type of white blood cell) that become abnormal and grow out of control. These lymphocytes produce large amounts of abnormal IgM antibodies that can make your blood too thick. 

We have detailed information about WM on our website and it is also covered in our Low-grade non-Hodgkin lymphoma book which can be downloaded or ordered for free.

You can also read or watch a range of personal stories from people with a lived experience of WM:

Would you like to share your experience of WM to help others? Share your story here.

As part of our Lymphoma Voices podcasts, Katie talks about her diagnosis of WM and about her decision to enter a clinical trial.

My experience of treatment on a clinical trial